Related references
Note: Only part of the references are listed.Emergence and establishment of KPC-2-producing ST11 Klebsiella pneumoniae in a general hospital in Shanghai, China
Jingxian Liu et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2018)
Ceftazidime/avibactam use for carbapenem-resistant Klebsiella pneumoniae meningitis: a case report
Amanda Holyk et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2018)
Pneumonia and Renal Replacement Therapy Are Risk Factors for Ceftazidime-Avibactam Treatment Failures and Resistance among Patients with Carbapenem-Resistant Enterobacteriaceae Infections
Ryan K. Shields et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
Colistin Versus Ceftazidime-Avibactam in the Treatment of Infections Due to Carbapenem-Resistant Enterobacteriaceae
David van Duin et al.
CLINICAL INFECTIOUS DISEASES (2018)
Emergence of Ceftazidime-Avibactam Resistance Due to Plasmid-Borne blaKPC-3 Mutations during Treatment of Carbapenem-Resistant Klebsiella pneumoniae Infections
Ryan K. Shields et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
In vitro activity of tigecycline in combination with rifampin, doripenem or ceftazidime against carbapenem-resistant Klebsiella pneumoniae bloodstream isolates
Yongbo Zhang et al.
JOURNAL OF ANTIBIOTICS (2017)
Carbapenem Resistance, Initial Antibiotic Therapy, and Mortality in Klebsiella pneumoniae Bacteremia: A Systematic Review and Meta-Analysis
Philipp P. Kohler et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2017)
Monotherapy of ceftazidime-avibactam and ceftolozane-tazobactam: two effective antimicrobial agents against multidrug-resistant organisms except for NDM-1 isolates
Benjamin Davido et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2017)
Successful ceftazidime-avibactam treatment of MDR-KPC-positive Klebsiella pneumoniae infection in a patient with traumatic brain injury A case report
Agnese Gugliandolo et al.
MEDICINE (2017)
Klebsiella pneumoniae Carbapenemase-2 (KPC-2), Substitutions at Ambler Position Asp179, and Resistance to Ceftazidime-Avibactam: Unique Antibiotic-Resistant Phenotypes Emerge from β-Lactamase Protein Engineering
Melissa D. Barnes et al.
MBIO (2017)
Klebsiella pneumoniae in Singapore: Hypervirulent Infections and the Carbapenemase Threat
Ka Lip Chew et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2017)
Pharmacokinetic-Pharmacodynamic Target Attainment Analyses To Determine Optimal Dosing of Ceftazidime-Avibactam for the Treatment of Acute Pulmonary Exacerbations in Patients with Cystic Fibrosis
Timothy J. Bensman et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Ceftazidime-Avibactam and Aztreonam, an Interesting Strategy To Overcome β-Lactam Resistance Conferred by Metallo-β-Lactamases in Enterobacteriaceae and Pseudomonas aeruginosa
Benjamin Davido et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Synergistic activity of ceftazidime-avibactam and aztreonam against serine and metallo-β-lactamase-producing gram-negative pathogens
Eric Wenzler et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2017)
Mortality Associated with Bacteremia Due to Colistin-Resistant Klebsiella pneumoniae with High-Level Meropenem Resistance: Importance of Combination Therapy without Colistin and Carbapenems
Isabel Machuca et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Outbreak of KPC-2-producing Enterobacteriaceae caused by clonal dissemination of Klebsiella pneumoniae ST307 carrying an IncX3-type plasmid harboring a truncated Tn4401a
Jung Ok Kim et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2017)
In vitro evaluation of dual carbapenem combinations against carbapenemase-producing Enterobacteriaceae
Laurent Poirel et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2016)
Pharmacodynamic Evaluation of the Potential Clinical Utility of Fosfomycin and Meropenem in Combination Therapy against KPC-2-Producing Klebsiella pneumoniae
James Albiero et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Outbreak of NDM-1-producing Klebsiella pneumoniae ST76 and ST37 isolates in neonates
J. Zhu et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2016)
Successful treatment of a Carbapenem-resistant Klebsiella pneumoniae carrying bla(OXA-48), bla(VIM-2), bla(CMY-2) and bla(SHV-) with high dose combination of imipenem and amikacin
Zied Hajjej et al.
IDCASES (2016)
First Report of OXA-181-Producing Escherichia coli in China and Characterization of the Isolate Using Whole-Genome Sequencing
Yanbin Liu et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Large hospital outbreak of KPC-2-producing Klebsiella pneumoniae: investigating mortality and the impact of screening for KPC-2 with polymerase chain reaction
T. Ducomble et al.
JOURNAL OF HOSPITAL INFECTION (2015)
The -Lactams Strike Back: Ceftazidime-Avibactam
Evan J. Zasowski et al.
PHARMACOTHERAPY (2015)
Emergence of OXA-48-Producing Klebsiella pneumoniae in Taiwan
Ling Ma et al.
PLOS ONE (2015)
Treating infections caused by carbapenemase-producing Enterobacteriaceae
L. S. Tzouvelekis et al.
CLINICAL MICROBIOLOGY AND INFECTION (2014)
A nosocomial outbreak of KPC-2-producing Klebsiella pneumoniae in a Chinese hospital: dissemination of ST11 and emergence of ST37, ST392 and ST395
J. Yang et al.
CLINICAL MICROBIOLOGY AND INFECTION (2013)
Treatment Outcome of Bacteremia Due to KPC-Producing Klebsiella pneumoniae: Superiority of Combination Antimicrobial Regimens
Zubair A. Qureshi et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Multiplex PCR for detection of acquired carbapenemase genes
Laurent Poirel et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2011)
In vitro evaluation of antibiotic synergy for NDM-1-producing Enterobacteriaceae
Beatrice Bercot et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2011)
In Vitro Evaluation of Antibiotic Synergy for Polymyxin B-Resistant Carbapenemase-Producing Klebsiella pneumoniae
Azza Elemam et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2010)
Multiplex PCR for rapid detection of genes encoding CTX-M extended-spectrum beta-lactamases
N Woodford et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2006)
Synergistic activity of colistin and ceftazidime against multiantibiotic-resistant Pseudomonas aeruginosa in an in vitro pharmacodynamic model
BW Gunderson et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
Share Paper
